At the completion of the investigation, based on the information received the following were confirmed; endoleak type iiia and secondary procedure.Additionally there was evidence to reasonably support the following observation; mal positioned of a non-endologix stent causing stent collapse/stenosis of the main body stent which limited blood flow.The review of manufacturing lot confirmed all devices met specifications prior to release.Devices remain implanted in the patient and were not returned, no evaluation completed.Clinical found evidence to reasonably suggest the following contributing factors to the reported event; off-label, near dual 90° angulation of the stent, and user error of mal positioned on the non-endologix stent.Unknown, there is not enough information available to determine the root cause of the reported event at this time.
|